Sokol H - Search Results

1

Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii.

Sokol H, Langella P. Sokol H, et al. Inflamm Bowel Dis. 2014 Jul;20(7):E18. doi: 10.1097/MIB.0000000000000071. Inflamm Bowel Dis. 2014. PMID: 24859301 No abstract available.

2

Specificities of the fecal microbiota in inflammatory bowel disease.

Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Doré J. Sokol H, et al. Inflamm Bowel Dis. 2006 Feb;12(2):106-11. doi: 10.1097/01.MIB.0000200323.38139.c6. Inflamm Bowel Dis. 2006. PMID: 16432374

3

Pure ileal Crohn's disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin Procedure) for Hirschsprung's disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn's disease.

Dray X, Sokol H, Vahedi K, Lavergne-Slove A, Marteau P. Dray X, et al. Among authors: sokol h. Inflamm Bowel Dis. 2007 Feb;13(2):243-4. doi: 10.1002/ibd.20002. Inflamm Bowel Dis. 2007. PMID: 17206715 No abstract available.

4

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

Sokol H, Lay C, Seksik P, Tannock GW. Sokol H, et al. Inflamm Bowel Dis. 2008 Jun;14(6):858-67. doi: 10.1002/ibd.20392. Inflamm Bowel Dis. 2008. PMID: 18275077 Review.

5

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

Seksik P, Dray X, Sokol H, Marteau P. Seksik P, et al. Among authors: sokol h. Mol Nutr Food Res. 2008 Aug;52(8):906-12. doi: 10.1002/mnfr.200700147. Mol Nutr Food Res. 2008. PMID: 18384087 Review.

6

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Sokol H, et al. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20. Proc Natl Acad Sci U S A. 2008. PMID: 18936492 Free PMC article. Clinical Trial.

7

Effects of light smoking consumption on the clinical course of Crohn's disease.

Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J. Seksik P, et al. Among authors: sokol h. Inflamm Bowel Dis. 2009 May;15(5):734-41. doi: 10.1002/ibd.20828. Inflamm Bowel Dis. 2009. PMID: 19067428 Clinical Trial.

8

Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.

Serrate C, Silva-Moreno M, Dartigues P, Poujol-Robert A, Sokol H, Gorin NC, Coppo P. Serrate C, et al. Among authors: sokol h. Inflamm Bowel Dis. 2009 Oct;15(10):1449-51. doi: 10.1002/ibd.20823. Inflamm Bowel Dis. 2009. PMID: 19177429 No abstract available.

9

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Sokol H, et al. Inflamm Bowel Dis. 2009 Aug;15(8):1183-9. doi: 10.1002/ibd.20903. Inflamm Bowel Dis. 2009. PMID: 19235886

10

Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal.

Sokol H, Seksik P, Nion-Larmurier I, Vienne A, Beaugerie L, Cosnes J. Sokol H, et al. Inflamm Bowel Dis. 2010 Mar;16(3):362-3. doi: 10.1002/ibd.20981. Inflamm Bowel Dis. 2010. PMID: 19462422 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results